Biocompatibles UK, a medical technology company involved in drug device combination products, has won an award for the development of an innovative cancer product.
The Farnham, Surrey based firm received the Institute of Materials, Minerals and Mining (IOM3) award for Polymers in the Service of Mankind for its DC Bead technology from HRH The Prince Philip, in a ceremony at Buckingham Palace.
DC Bead is a polymer-based engineering solution that ultimately deprives cancer of the nutrients and oxygen that enable it to spread. It is used in a procedure called Transarterial Chemoembolisation (TACE), a minimally invasive medical procedure to restrict a tumour's blood supply. TACE has been used extensively to delay the progression of hepatocellular carcinoma (HCC), a type of liver cancer.
Biocompatibles UK’s main aim is to deliver products that are safe to use, economically viable, with clear clinical advantages. The firm's products use specialised polymer technology engineered to allow ease of delivery to blood vessels of tumours combined with controlled drug delivery capability. It is a pioneer in the use of drug-eluting beads to treat cancer.
Biocompatibles UK Ltd has been part of BTG International group company since 2008.
The Prince Philip award was established in 1973 and is awarded biennually (subject to sufficient merit).
Biocompatibles wins IOM3 award for DC Bead technology
Polymer-based engineering solution deprives cancer cells of nutrients they need to survive
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Drug Delivery
AI might find the molecule, but delivery decides whether it becomes a medicine
As the pharmaceutical industry scales AI-driven discovery at unprecedented speed, will the early integration of formulation and manufacturability determine which computationally promising molecules become deliverable medicines?
Pharmaceutical
Optimising process steps and performance with agitated Nutsche filter-dryers
Agitated Nutsche filter dryers (ANFD) streamline solid-liquid separation by performing filtration, dewatering, and drying in a single sealed vessel; an enormous boon in fine chemicals and pharmaceutical production
Drug Delivery
Automating processes for effective scale-up with the GFD Lab PLUS Filter Dryer
Scale-up is a persistent challenge in fine chemical and pharmaceutical manufacturing. Countless challenges arise when translating workflows from the lab, or pilot-scale, to commercial production. But issues can occur even earlier. Inconsistencies during early development can lead directly to scale-up failures
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.